Weight loss injection study for adults with obesity
Part of Hormones & metabolism clinical trials.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 to 75 years old
- You have a BMI of 30 or higher, or a BMI between 27 and 30 with a weight-related health condition (like high blood pressure, high cholesterol, sleep apnea, or prediabetes)
- You have tried to lose weight before with diet and exercise but weren't successful
- You are willing to follow a reduced-calorie diet and exercise program for the study
- You are not taking any weight-loss medications, diabetes medications, or other drugs that affect weight right now
- You do not have diabetes, a history of certain stomach or pancreas problems, or a personal or family history of a rare thyroid cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
Hear when a new Obesity &Amp; Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.